Author

Ruggero Ponz de Leon Pisani

DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT IN PANCREATIC CANCER INFLUENCE OVERALL SURVIVAL
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT IN PANCREATIC CANCER INFLUENCE OVERALL SURVIVAL

Ruggero Ponz de Leon Pisani  et al.

CHANGES OF ORAL AND DUODENAL MICROBIOTA IN PATIENTS WITH PANCREATIC CANCER ARE POSSIBLE DIAGNOSTIC AND PROGNOSTIC BIOMARKERS
CHANGES OF ORAL AND DUODENAL MICROBIOTA IN PATIENTS WITH PANCREATIC CANCER ARE POSSIBLE DIAGNOSTIC AND PROGNOSTIC BIOMARKERS

Ruggero Ponz de Leon Pisani  et al.

CURRENT SMOKING IS ASSOCIATED WITH SHORTER PROGRESSION-FREE SURVIVAL IN PANCREATIC CANCER PATIENTS TREATED WITH FIRST-LINE FOLFIRINOX, BUT NOT WITH OTHER INTENSIFIED REGIMENS
CURRENT SMOKING IS ASSOCIATED WITH SHORTER PROGRESSION-FREE SURVIVAL IN PANCREATIC CANCER PATIENTS TREATED WITH FIRST-LINE FOLFIRINOX, BUT NOT WITH OTHER INTENSIFIED REGIMENS

Ruggero Ponz de Leon Pisani  et al.

A BASAL-LIKE PANCREATIC CANCER MOLECULAR SUBTYPE CAN BE IDENTIFIED ON EUS-ACQUIRED TISSUE AND IS ASSOCIATED TO CURRENT SMOKING, LOWER CA19.9 EXPRESSION AND WORSE PROGNOSIS
A BASAL-LIKE PANCREATIC CANCER MOLECULAR SUBTYPE CAN BE IDENTIFIED ON EUS-ACQUIRED TISSUE AND IS ASSOCIATED TO CURRENT SMOKING, LOWER CA19.9 EXPRESSION AND WORSE PROGNOSIS

Ruggero Ponz de Leon Pisani  et al.

CONTINUOUS SMOKING MAY PLAY A ROLE IN THE PROGRESSION FROM “TRIVIAL” (THE GOOD) BD-IPMNS TO IPMNS WITH AN INDICATION FOR SURGERY (“THE BAD”) AND PANCREATIC CANCER (THE “UGLY”)
CONTINUOUS SMOKING MAY PLAY A ROLE IN THE PROGRESSION FROM “TRIVIAL” (THE GOOD) BD-IPMNS TO IPMNS WITH AN INDICATION FOR SURGERY (“THE BAD”) AND PANCREATIC CANCER (THE “UGLY”)

Ruggero Ponz de Leon Pisani  et al.

THE IMPACT OF A MULTIDISCIPLINARY TEAM EVALUATION ON THE DIAGNOSIS AND MANAGEMENT OF ACUTE AND CHRONIC PANCREATITIS IN A TERTIARY REFERRAL CENTER
THE IMPACT OF A MULTIDISCIPLINARY TEAM EVALUATION ON THE DIAGNOSIS AND MANAGEMENT OF ACUTE AND CHRONIC PANCREATITIS IN A TERTIARY REFERRAL CENTER

Ruggero Ponz de Leon Pisani  et al.

Item 1 - 6 / 6
1